A previous randomized controlled trial in adults with type 2 diabetes treated with intensive insulin therapy found no significant differences in hemoglobin A1c (HbA1c) levels after 6 months of CGM or SMBG treatment. Here, INS is linked to type 2 diabetes mellitus.